Product Information
OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1511 per ML under NDC 70710116506. Its NADAC has been published 443 times since Feb 28, 2018.
FDA first approved this application on Sep 14, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
6 mg/mL
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710116506
Classification
Generic
Dosage Form
FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA209113FDA Approved
9/14/2017
TE Code
AB
On Market Since
9/14/2017
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 443 times since Feb 28, 2018, and over the history we have for it it has declined 90.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1511 per ML |
|---|---|
| All-time high | $1.5268 (Apr 11, 2018) |
| All-time low | $0.1271 (Nov 20, 2024) |
| 52-week high | $0.1739 |
| 52-week low | $0.1497 |
| Median price | $0.3966 |
| Average price | $0.5380 |
| Largest weekly change | -56.9% (Sep 20, 2023) |
| Weeks tracked | 443 |
| Tracking since | Feb 28, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the oseltamivir phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1511 per ML (NDC 70710116506), effective Aug 19, 2026.
How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 90.1%. It has been tracked across 443 weekly CMS publications since Feb 28, 2018.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?
Since Feb 28, 2018, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $1.5268 (Apr 11, 2018), with a median of $0.3966 per ML.
Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of OSELTAMIVIR 6 MG/ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?
OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 70710116506) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.